Consistent with these observations, we now demonstrate the presence of circulating IFI16 protein in the sera of patients affected by systemic autoimmune diseases, but not in patients with non-autoimmune inflammatory diseases like non-SLE GN. Here, IFI16 is linked to ganglioneuroma.